Diaralia

Arsenic Trioxide, Cinchona Officinalis Bark, Podophyllum

Boiron
Human Otc Drug
NDC 0220-9097

Diaralia also known as Arsenic Trioxide, Cinchona Officinalis Bark, Podophyllum is a human otc drug labeled by 'Boiron'. National Drug Code (NDC) number for Diaralia is 0220-9097. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Diaralia drug includes Arsenic Trioxide - 9 [hp_C]/1 Cinchona Officinalis Bark - 5 [hp_C]/1 Podophyllum - 9 [hp_C]/1 . The currest status of Diaralia drug is Active.

Drug Information:

Drug NDC:	0220-9097
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Diaralia
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Arsenic Trioxide, Cinchona Officinalis Bark, Podophyllum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Boiron
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Pellet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARSENIC TRIOXIDE - 9 [hp_C]/1 CINCHONA OFFICINALIS BARK - 5 [hp_C]/1 PODOPHYLLUM - 9 [hp_C]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	09 May, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Boiron
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	S7V92P67HO S003A158SB 2S713A4VP3
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
0220-9097-42	2 TUBE in 1 BOX (0220-9097-42) / 80 PELLET in 1 TUBE (0220-9097-41)	09 May, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Diaralia

Arsenic Trioxide, Cinchona Officinalis Bark, Podophyllum

Pellet
Boiron
NDC: 0220-9097

Purpose:

Purpose* âarsenicum album 9c hpus (0.15 mg) .... relieves diarrhea with nausea, vomiting, and weakness cinchona officinalis 5c hpus (0.15 mg) ... relieves diarrhea with gas and bloating podophyllum peltatum 9c hpus (0.15 mg) ... relieves diarrhea with intestinal rumbling and pain

Product Elements:

Diaralia arsenic trioxide, cinchona officinalis bark, podophyllum podophyllum podophyllum cinchona officinalis bark cinchona officinalis bark arsenic trioxide arsenic cation (3+) lactose, unspecified form sucrose

Indications and Usage:

Uses* temporarily relieves symptoms of diarrhea such as: traveler's diarrhea intestinal pain bloating gas nausea vomiting

Warnings:

Dosage and Administration:

Drink plenty of clear fluids to help prevent dehydration cause by diarrhea. adults and children 6 years of age and older: at the onset of symptoms, dissolve 5 pellets under the tongue every 4 to 6 hours, up to 2 days maximum. discontinue use as soon as symptoms disappear. children under 6 years of age: ask a doctor.

Stop Use:

Stop use and ask a doctor if symptoms persist for more than 2 days or worsen.

Package Label Principal Display Panel:

Label label

Further Questions:

1-800-264-7661 made in france distributed by boiron, inc. newtown square, pa â19073

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.